Aligos Therapeutics Statistics

Total Valuation

ALGS has a market cap or net worth of $147.87 million. The enterprise value is $82.08 million.

Market Cap	147.87M
Enterprise Value	82.08M

Important Dates

The last earnings date was Wednesday, November 6, 2024, after market close.

Earnings Date	Nov 6, 2024
Ex-Dividend Date	n/a

Share Statistics

ALGS has 3.71 million shares outstanding. The number of shares has increased by 246.07% in one year.

Current Share Class	3.59M
Shares Outstanding	3.71M
Shares Change (YoY)	+246.07%
Shares Change (QoQ)	+0.10%
Owned by Insiders (%)	4.73%
Owned by Institutions (%)	19.47%
Float	1.83M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	39.65
Forward PS	101.14
PB Ratio	2.64
P/TBV Ratio	2.95
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	13.69
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.81, with a Debt / Equity ratio of 0.18.

Current Ratio	3.81
Quick Ratio	3.58
Debt / Equity	0.18
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -146.69% and return on invested capital (ROIC) is -93.25%.

Return on Equity (ROE)	-146.69%
Return on Assets (ROA)	-67.32%
Return on Capital (ROIC)	-93.25%
Revenue Per Employee	$90,864
Profits Per Employee	-$1.17M
Employee Count	66
Asset Turnover	0.07
Inventory Turnover	n/a

Taxes

In the past 12 months, ALGS has paid $274,000 in taxes.

Income Tax	274,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +170.10% in the last 52 weeks. The beta is 2.73, so ALGS's price volatility has been higher than the market average.

Beta (5Y)	2.73
52-Week Price Change	+170.10%
50-Day Moving Average	18.61
200-Day Moving Average	16.23
Relative Strength Index (RSI)	80.75
Average Volume (20 Days)	428,838

Short Selling Information

The latest short interest is 283,759, so 7.65% of the outstanding shares have been sold short.

Short Interest	283,759
Short Previous Month	291,505
Short % of Shares Out	7.65%
Short % of Float	15.48%
Short Ratio (days to cover)	0.50

Income Statement

In the last 12 months, ALGS had revenue of $6.00 million and -$76.95 million in losses. Loss per share was -$12.89.

Revenue	6.00M
Gross Profit	-70.50M
Operating Income	-93.86M
Pretax Income	-75.52M
Net Income	-76.95M
EBITDA	-92.68M
EBIT	-93.86M
Loss Per Share	-$12.89

Full Income Statement

Balance Sheet

The company has $74.92 million in cash and $9.13 million in debt, giving a net cash position of $65.79 million or $17.73 per share.

Cash & Cash Equivalents	74.92M
Total Debt	9.13M
Net Cash	65.79M
Net Cash Per Share	$17.73
Equity (Book Value)	50.10M
Book Value Per Share	15.07
Working Capital	58.87M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$85.00 million and capital expenditures -$109,000, giving a free cash flow of -$85.11 million.

Operating Cash Flow	-85.00M
Capital Expenditures	-109,000
Free Cash Flow	-85.11M
FCF Per Share	-$22.93

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-1,565.18%
Pretax Margin	-1,278.62%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ALGS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-246.07%
Shareholder Yield	-246.07%
Earnings Yield	-52.04%
FCF Yield	-57.56%

Analyst Forecast

The average price target for ALGS is $75.00, which is 88.25% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$75.00
Price Target Difference	88.25%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	79.71%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on August 19, 2024. It was a reverse split with a ratio of 0.04:1.

Last Split Date	Aug 19, 2024
Split Type	Reverse
Split Ratio	0.04:1

Scores

ALGS has an Altman Z-Score of -10.34 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-10.34
Piotroski F-Score	1